LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K083412
    Device Name
    PATHFAST HSCRP
    Manufacturer
    MITSUBISHI KAGAKU IATRON
    Date Cleared
    2009-03-09

    (111 days)

    Product Code
    DCN,JIT
    Regulation Number
    866.5270
    Type
    Traditional
    Panel
    Clinical Chemistry
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    PATHFAST HSCRP

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    PATHFAST® hsCRP test, for use with PATHFAST® analyzer, is an in vitro diagnostic test for the quantitative measurement of C-reactive protein (CRP) in heparinized or EDTA whole blood, plasma, and serum, as an aid in the detection and evaluation of the infection, tissue injury, inflammatory disorders, and associated disorders. This method is for use in clinical laboratory or point of care (POC) settings.

    PATHFAST® hsCRP Calibrator is an in vitro diagnostic product for the calibration of the C-reactive protein (CRP) method on the PATHFAST® System.

    Device Description

    Not Found

    AI/ML Overview

    This document is a 510(k) clearance letter from the FDA for a diagnostic device. It does not contain the detailed study information or acceptance criteria requested.

    The letter confirms that the PATHFAST hsCRP test is substantially equivalent to legally marketed predicate devices. To provide the requested information, I would need to analyze the actual 510(k) submission document (K083412), which is not provided here.

    Therefore, I cannot fulfill your request for:

    1. A table of acceptance criteria and reported device performance.
    2. Sample sizes and data provenance for the test set.
    3. Number and qualifications of experts for ground truth.
    4. Adjudication method for the test set.
    5. MRMC comparative effectiveness study details.
    6. Standalone performance details.
    7. Type of ground truth used.
    8. Sample size for the training set.
    9. How ground truth was established for the training set.

    The provided document is merely the FDA's clearance letter acknowledging the 510(k) submission and its determination of substantial equivalence. The actual performance data and study details would be in the submission itself.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1